The FDA’s recent decision not to regulate CBD like a food or dietary supplement leaves a multi-billion-dollar industry in a lurch. What’s next, and what should companies do now?...more
The cannabis world is abuzz with news about the latest federal Food & Drug Administration (FDA) report regarding cannabidiol (CBD). We break down what it is, and what it means for the industry and the regulatory landscape for...more
3/9/2020
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Corporate Counsel ,
Department of Health and Human Services (HHS) ,
E-Cigarettes ,
Enforcement Programs ,
Food and Drug Administration (FDA) ,
Information Reports ,
Regulatory Agencies ,
Regulatory Agenda
On October 31, 2019, the US Department of Agriculture (USDA) published a long-anticipated interim final rule on the production of hemp - defined as cannabis plant with a delta-9 tetrahydrocannabinol (THC) concentration of not...more
11/14/2019
/ Administrative Procedure ,
Cannabis Products ,
Clinical Laboratory Testing ,
Comment Period ,
Controlled Substances Act ,
Farm Bill ,
Hemp ,
Interim Final Rules (IFR) ,
Marijuana ,
Marijuana Related Businesses ,
Market Participants ,
Regulatory Agenda ,
Testing Requirements ,
Tribal Governments ,
USDA